Where is Fujis cardiac imaging line headed?
Cooke: As far as the overall medical business for Fuji, it’s a very important part of our portfolio. It’s a very rapidly growing area. And I think one of the key trends happening in radiology and cardiology is that there’s a significant crossover that is in the process of occurring, particularly in the area of cardiac CT. So we feel that, obviously, this is going to be an important area for the future, while we merge Fuji’s capability at dealing with CT data with ProSolv’s experience in the cardiovascular department. That’s going to be an important strategic area for us.
